# Study of Oglemilast for the Prevention of Asthma.

> **NCT00322283** · PHASE2 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 24 (actual)

## Conditions studied

- Exercise-Induced Asthma

## Interventions

- **DRUG:** Oglemilast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00322283
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322283, "Study of Oglemilast for the Prevention of Asthma.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00322283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*